Table 1. Baseline clinical features of subjects with COVID-19 in different ages.
All patients(n = 32) | Age <60 years old(n = 13) | Age≥60 years old(n = 19) | P- value | |
---|---|---|---|---|
Sex–No., % | ||||
male | 17(53.1%) | 4(30.8%) | 13(68.4%) | 0.070 |
Exposure–No., % | 25(78.1%) | 10(76.9%) | 15(78.9%) | 1.000 |
Entering Symptoms–No., % | ||||
Fever | 30(93.8%) | 12(92.3%) | 18(94.7%) | 1.000 |
Cough | 14(43.8%) | 5(38.5%) | 9(47.4%) | 0.725 |
Expectoration | 6(18.8%) | 1(7.7%) | 5(26.3%) | 0.361 |
Fatigue | 11(34.4%) | 3(23.1%) | 8(42.1%) | 0.450 |
Headache | 4(12.5%) | 3(23.1%) | 1(5.3%) | 0.279 |
Diarrhea | 3(9.4%) | 2(15.4%) | 1(5.3%) | 0.552 |
Comorbidities–No., % | ||||
≥two comorbidities | 15(46.9%) | 5(38.5%) | 10(52.6%) | 0.491 |
COPD | 4(12.5%) | 0(0.0%) | 4(21.1%) | 0.128 |
Hypertension | 10(31.3%) | 4(30.8%) | 6(31.6%) | 1.000 |
Diabetes | 8(25.0%) | 3(23.1%) | 5(26.3%) | 1.000 |
Cardiovascular disease | 4(12.5%) | 0(0.0%) | 4(21.1%) | 0.128 |
Cerebrovascular disease | 4(12.5%) | 1(7.7%) | 3(15.8%) | 0.629 |
Chronic kidney disease | 3(9.4%) | 2(15.4%) | 1(5.3%) | 0.552 |
Time from onset to, media(IQR), d | ||||
diagnosis | 7(5–11) | 9(3–13.5) | 7(5–9) | 0.448 |
ICU | 18.0(12.25–21.75) | 20.0(12.5–25.5) | 17(12–19) | 0.170 |
mechanical ventilation | 14(9–19) | 14(10.5–19.5) | 11(8.5–19) | 0.467 |
Abbreviations: ARDS, Acute respiratory distress syndrome; HBV, Hepatitis B virus; COPD, Chronic obstructive pulmonary disease.